Although USP25 protein levels remain unchanged in patients with AD compared with controls without AD, more attention should be given to the catalytic activity of USP25, a ubiquitin-specific protease, and future studies will carefully characterize the regulatory mechanism of USP25 catalytic activity in the brain in the context of AD and related disorders. Here, USP25 is linked to Alzheimer disease.